Skip to main content
Clinical Trials/IRCT20190928044913N1
IRCT20190928044913N1
Completed
Phase 3

Survey The Effect Of Anticholinergic Drug On Uroflowmetry In Patients With Benign Prostatic Hyperplasia

Sabzevar University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Benign Prostatic Hyperplasia.
Sponsor
Sabzevar University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Sabzevar University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patient Whit Benign Prostatic Hyperplasia treat with a Blaker

Exclusion Criteria

  • Past Mediacal History of Prostatic cancer
  • Age underb 50 years
  • Past Medical History Prostatic surgery
  • Past Medical History Of neurology illness
  • History Of Use Anticholinergic In 2 Past Week

Outcomes

Primary Outcomes

Not specified

Similar Trials